← Evidence map

ArticleBMJ case reports2017

Nintedanib as a novel treatment option in hereditary haemorrhagic telangiectasia.

Evelin Kovacs-Sipos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

14 papers cite it

2017
2018
2019
2020
2021
2022
2023
2024
2025
this papertrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 28652319